“…Several cases of secondary involvement of the ovary by diffuse malignant peritoneal mesothelioma have been reported in the literature; more rarely, ovarian primary malignant mesothelioma may involve the peritoneum [ 81 , 82 ]. Indeed, clinical and morphological distinction between some entities (e.g., well-differentiated peritoneal mesothelioma or florid peritoneal mesothelial proliferations) may be difficult due to some overlapping morphological and immunohistochemical (IHC) features, including papillary structures, clinical symptoms and imaging findings [ 96 , 97 , 98 , 99 , 100 , 101 , 102 , 103 , 104 , 105 , 106 , 107 , 108 , 109 , 110 , 111 , 112 , 113 ]. This is mainly true if we also consider the new knowledge on the emerging entity of the mesothelioma in situ that can remain hidden for a long time [ 114 , 115 ].…”